Immunomodulation due to plasma or plasma-platelet apheresis donation: Events occurring during donation procedures

Journal of Clinical Apheresis

Volumn 30, Issue 4, 2015, Pages 204-211

  Ghio, Massimo ^a   Contini, Paola ^a   Ansaldi, Filippo ^a,b   Ubezio, Gianluca ^a   Setti, Maurizio ^a   Risso, Marco ^c   Tripodi, Gino ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b Department of Health Sciences   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

apheresis; donor; immunomodulation; sHLA; TGF 1

Indexed keywords

FAS LIGAND; HLA ANTIGEN CLASS 1; TRANSFORMING GROWTH FACTOR BETA1; FASLG PROTEIN, HUMAN; MONOCLONAL ANTIBODY; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN BINDING; ARTICLE; BLOOD CELL; BLOOD DONOR; CD8+ T LYMPHOCYTE; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; MALE; PLASMAPHERESIS; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THROMBOCYTOPHERESIS; BLOOD; CHEMISTRY; CYTOLOGY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; IMMUNOLOGY; LEUKOCYTE; LYMPHOCYTE ACTIVATION; METABOLISM; PLASMA; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTE;

ANTIBODIES, MONOCLONAL; BLOOD DONORS; BLOOD PLATELETS; FAS LIGAND PROTEIN; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOMODULATION; LEUKOCYTES; LYMPHOCYTE ACTIVATION; MALE; MICROSCOPY, FLUORESCENCE; PLASMA; PLATELETPHERESIS; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84939466560     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.21362     Document Type: Article

References (37)

1. Ghio M, Contini P, Mazzei C, Brenci S, Barberis G, Filaci G, Indiveri F, Puppo F,. Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions. Blood 1999; 3: 1770-1777.
2. + T lymphocytes and neutrophils after intravenous immunoglobulin treatment. Transfusion 2010; 50: 547-555.
3. Ghio M, Contini P, Ottonello L, Arduino N, Gringeri A, Indiveri F, Dallegri F, Puppo F,. Effect of clotting factors concentrates on lymphocyte and neutrophil function in vitro. Thromb Haemost 2003; 89: 365-373.
4. Agishi T,. Birth of the concept and the development of extracorporeal immunomodulation. Ther Apher 2002; 6: 312-316.
5. Ansorge W, Spindler E, Vienken J, Baurmeister U,. Membranes and polymer structures-biocompatibility aspects with respect to production limits. Transfus Sci 1993; 14: 199-209.
6. Siami GA, Siami FS,. Membrane plasmapheresis in the United States: a review over the last 20 years. Ther Apher 2001; 5: 315-320.
7. Sueoka A,. Present status of apheresis technologies: Part 1. Membrane plasma separator. Ther Apher 1997; 1: 42-48.
8. Huang Z, Gao D, Letteri JJ, Clark WR,. Blood-membrane interactions during dialysis. Semin Dialysis 2009; 22: 623-628.
9. Ghio M, Contini P, Ansaldi F, Ubezio G, Setti M, Risso M, Tripodi G,. A possible role of soluble HLA-I molecule in the immunomodulatory effects of therapeutic apheresis. Blood Transfus 2014; 12 Suppl 1: s167-s169.
10. Davenport MP, Smith KJ, Barouch D, Reid SW, Bodnar WM, Willis AC, Hunt DF, Hill AV,. HLA class I binding motifs derived from random peptide libraries differ at the COOH terminus from those of eluted peptides. J Exp Med 1997; 185: 367-371.
11. Ren D, Wang F, He X, Jiang L, Li D, Ying H, Sun S,. Construction of bioactive chimeric MHC class I tetramer by expression and purification of human-murine chimeric MHC heavy chain and beta (2)μ as a fusion protein in Escherichia coli. Protein Expr Purif 2006; 50: 171-178.
12. Tanigaki N,. The specificity and efficiency of endogenous peptides in the induction of HLA class I alpha chain refolding. Eur J Immunol 1992; 22: 2177-2180.
13. Contini P, Ghio M, Merlo A, Poggi A, Indiveri F, Puppo F,. Apoptosis of antigen-specific T lymphocytes upon the engagement of CD8 by soluble HLA class I molecules is Fas ligand/Fas mediated: evidence for the involvement of p56lck, calcium calmodulin kinase II, and Calcium-independent protein kinase C signaling pathways and for NF-kappaB. J Immunol 2005; 175: 7244-7254.
14. Allard M, Oger R, Benlalam H, Florenceau L, Echasserieau K, Bernardeau K, Labarrière N, Lang F, Gervois N,. Soluble HLA-I/peptide monomers mediate antigen-specific CD8 T cell activation through passive peptide exchange with cell-bound HLA-I molecules. J Immunol 2014; 192: 5090-5097.
15. Puppo F, Contini P, Ghio M, Brenci S, Scudeletti M, Filaci G, Ferrone S, Indiveri F,. Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8 (+) Fas (CD95)(+) T lymphocytes. Intl Immunol 2000; 12: 195-203.
16. Ilmakunnas M, Pesonen EJ, Ahonen J, Rämö J, Siitonen S, Repo H,. Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass. J Thorac Cardiovasc Surg 2005; 129: 851-859.
17. Cohen JA, Beaudette TT, Tseng WW, Bachelder EM, Mende I, Engleman EG, Fréchet JM,. T-cell activation by antigen-loaded pH-sensitive hydrogel particles in vivo: the effect of particle size. Bioconjug Chem 2009; 20: 111-119.
18. Moreira Pda L, Marreco PR, Moraes AM, Wada ML, Genari SC,. Analysis of cellular morphology, adhesion, and proliferation on uncoated and differently coated PVC tubes used in extracorporeal circulation (ECC). J Biomed Mater Res B Appl Biomater 2004; 69: 38-45.
19. Decreto Legge del 3 marzo 2005: Protocolli per l'accertamento della idoneità del donatore di sangue ed emocomponenti. Gazzetta Ufficiale della Repubblica Italiana Serie Generale n. 85 del 13 aprile 2005.
20. Burgstaler EA,. Blood component collection by apheresis. J Clin Apher 2006; 21: 142-151.
21. Patel AP, Kaur A, Patel V, Patel N, Shah D, Kanvinde S, Prajapati S, Patel H, Rathod D, Adesara R, Rani S,. Comparative study of plateletpheresis using Baxter CS 3000 plus and Haemonetics MCS 3P. J Clin Apher 2004; 19: 137-141.
22. Picker SM, Radojiska SM, Gathof BS,. Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors. Transfusion 2006; 46: 1601-1608.
23. Burgstaler EA, Winters JL, Pineda AA,. Paired comparison of Gambro Trima Accel versus Baxter Amicus single-needle plateletpheresis. Transfusion 2004; 44: 1612-1620.
24. Tanabe M, Sekimata M, Ferrone S, Takiguchi M,. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I alpha 3 domain. J Immunol 1992; 148: 3202-3209.
25. Pellegrino MA, NG AK, Russo C, Ferrone S,. Heterogeneous distribution of the determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules. Transplantation 1982; 34: 18-23.
26. Lenkei R, Bratt G, Holmberg V, Muirhead K, Sandström E,. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls. Cytometry 1998; 33: 115-122.
27. Nishanian P, Hofmann B, Wang Y, Jackson AL, Detels R, Fahey JL,. Serum soluble CD8 molecule is a marker of CD8 T-cell activation in HIV-1 disease. AIDS 1991; 5: 805-812.
28. Nakamura S, Sung SS, Bjorndahl JM, Fu SM,. Human T cell activation. IV. T cell activation and proliferation via the early activation antigen EA 1. J Exp Med 1989; 169: 677-689.
29. Ottonello L, Tortolina G, Amelotti M, Dallegri F,. Soluble Fas ligand is chemotactic for human neutrophil polymorphonuclear leukocytes. J Immunol 1999; 162: 3601-3606.
30. Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N, Barbany G, Cazzaniga G, Cayuela JM, Cave H, Pane F, Aerts JL, De Micheli D, Thirion X, Pradel V, Gonzalez M, Viehmann S, Malec M, Saglio G, van Dongen JJ,. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia-a Europe Against Cancer program. Leukemia 2003; 17: 2318-2357.
31. Ciotti P, Garuti A, Ballestrero A, Cirmena G, Chiaramondia M, Baccini P, Bellone E, Mandich P,. Reliability and reproducibility of a RNA preamplification method for low-density array analysis from formalin-fixed paraffin-embedded breast cancer samples. Diagn Mol Pathol 2009; 18: 112-118.
32. Zavazava N, Krönke M,. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat Med 1996; 2: 1005-1010.
33. Zimmermann R, Loew D, Weisbach V, Strasser E, Ringwald J, Zingsem J, Eckstein R,. Plateletpheresis does not cause long-standing platelet-derived growth factor release into the donor blood. Transfusion 2005; 45: 414-419.
34. Senhauser DA, Westphal RG, Bohman JE, Neff JC,. Immune system changes in cytapheresis donors. Transfusion 1982; 22: 302-304.
35. Richa E, Krueger P, Burgstaler EA, Bryant SC, Winters JL,. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts. Transfusion 2008; 48: 1325-1332.
36. Prior CR, Coghlan PJ, Hall JM, Jacobs P,. In vitro study of immunologic changes in long-term cytapheresis donors. J Clin Apher 1991; 6: 69-76.
37. Braine HG, Elfenbein GJ, Mellits ED,. Peripheral blood lymphocyte numbers, lymphocyte proliferative responses in vitro, and serum immunoglobulins in regular hemapheresis donors. J Clin Apher 1985; 2: 213-218.